EUR) per year. In total, parallel imports reduced the cost for on-patent pharmaceuticals by 4%. When discounts were …

market. However, listed companies upstream and downstream of Taiwan's supply chain have been facing patent infringement … lawsuits in recent years. This research mainly aims to provide investors with investment strategies when companies face patent … positive abnormal returns are generated before and after a company faces patent litigation and the cumulative abnormal rewards …

This paper analyzes how injunctions relate to patent hold-up problems. To this end, we present a simple model of … licensing negotiations between a patent holder and a downstream firm in the shadow of litigation. More specifically, we consider … the situation in which an injunction is granted as a matter of course if a patent is found valid and infringed upon in …

savings compared with policies targeting at patent-protected drugs, although the latter account for more than halve of the …

“reference mode”, determined the causal loop of the pharmaceuticals phase of PLC based on both an in-depth literature review and …